Senhance Robotic Platform in Pediatrics: Early US Experience

Area of Science:

• Minimally invasive surgery
• Pediatric surgical robotics
• Surgical technology adoption

Background:

• Established robotic systems often lack features crucial for pediatric surgery.
• Pediatric patients have unique anatomical and physiological considerations for surgical interventions.

Observation:

• The Senhance robotic system was evaluated in eight pediatric patients aged 4 months to 17 years.
• Procedures included cholecystectomy, inguinal herniorrhaphy, orchidopexy, and cyst exploration.
• The system demonstrated feasibility and ease of use in this cohort.

Findings:

• All robotic procedures were completed successfully, with no blood loss or complications.
• The 4-month-old, 8 kg patient underwent successful robotic exploration.
• 3 mm instruments facilitated successful robotic manipulation in all cases.

Implications:

• The Senhance system shows promise as a safe and effective option for pediatric surgery.
• The platform appears suitable for a wide range of pediatric patients, regardless of age or weight.
• Further evaluation of the Senhance robotic platform in pediatric surgery is warranted.